Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -58.3% | -7.1% | 1 / 3 | +4.6% | +7.20 pp | -1.81 pp | +17.3% | 0.08 | 6.55 | 737 | +4,6% | 64,8 | −13,3% | 6.55 | 12.83 | −48,9% |
| Pts | 0 | 0 | 4 | 0 | 12 | 4 | 8 | 12 | 12 | |||||||
Valuation annotation:Price: 36.250 (close price on 2026-10-19)EPS (TTM): 5.531
Financial charts
1.Revenue & growth
VND bn737Q2/26
1.Revenue & growth
VND bn737Q2/26
2.Profit & growth
VND bn57,7Q2/26
3.Profit mix (Penman)
VND bn374Q2/26
4.Margins & cost structure
%56.8%Q2/26
5.Returns & cash cycle
% · days25.1%Q2/26
6.Earnings quality & cash
VND bn267Q2/26
7.Asset structure
VND bn2.359Q2/26
8.Funding & debt health
VND bn · times2.359Q2/26
9.Revenue backlog
VND bn35,7Q2/26
10.Valuation
times · %11,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.393Q2/26
Adjusted EPS growth, latest quarter
-16.5%
Average adjusted EPS growth, 3 quarters
6.8%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26